Schizophrenia research and treatment

Schizophrenia is a severe psychiatric disorder characterized by psychosis, disorganized thinking, and persistent difficulties in memory, attention, and social reasoning, with symptoms often emerging in late adolescence before a full clinical picture becomes clear. Researchers are working to understand how genetic risk, disrupted neurodevelopment, and dopamine dysfunction converge to produce these effects, and why current antipsychotic drugs — while effective against hallucinations and delusions — do little to address the neurocognitive deficits that most limit daily functioning. A major open question is whether early intervention during the prodromal phase can meaningfully alter the course of illness, and how cognitive and social therapies can be integrated with pharmacological treatment to target the full range of impairments. Complicating matters further, antipsychotic use is associated with metabolic syndrome, making long-term management a careful balance between psychiatric and physical health.

Works

141,580

Total citations

3,362,217

Keywords

Antipsychotic DrugsNeurocognitive DeficitsGenetic Association StudiesMetabolic SyndromeNeurodevelopmental ModelCognitive Therapy